What is WES Pharma?
WES Pharma Inc. is a privately held specialty pharmaceutical firm headquartered in Westminster, MD. The company focuses on the research, development, manufacturing, and marketing of both over-the-counter (OTC) and prescription (Rx) generic products. Operating from a modern 32,000-square-foot facility, WES Pharma is equipped for the formulation of solid and liquid dosage forms. Its scientific team utilizes advanced methodologies to develop products that adhere to FDA standards, targeting healthcare providers and organizations seeking reliable generic pharmaceutical solutions.
How much funding has WES Pharma raised?
WES Pharma has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in WES Pharma
PPP
Public-Private Partnership
What's next for WES Pharma?
The recent strategic investment positions WES Pharma for accelerated growth and market penetration. As a company in a large-scale, late-stage funding phase, WES Pharma is likely to leverage this capital to enhance its manufacturing capabilities, broaden its R&D pipeline for new generic formulations, and expand its distribution networks. This infusion of financing is expected to solidify its market presence and potentially lead to further strategic partnerships or acquisitions within the pharmaceutical sector.
See full WES Pharma company page
